SIBN — SI-BONE, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1459839 ·
Last close
$14.67
Market Cap
$650.60M
52W High
$16.12
52W Low
$11.48
ADV30
756,779
Next earnings
2026-08-03
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 52,588,000 41,944,000 -5,093,000 -4,334,000 242,718,000 33,535,000 63,776,000
Dec 2025 56,349,000 44,531,000 -2,463,000 -1,644,000 238,555,000 42,240,000 61,023,000
Sep 2025 48,656,000 38,846,000 -5,383,000 -4,566,000 234,273,000 26,487,000 62,147,000
Jun 2025 48,630,000 38,807,000 -7,004,000 -6,152,000 230,921,000 34,150,000 60,578,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-675,000
Investing CF
$4,160,000
Financing CF
$3,376,000
CapEx
$-8,414,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.44
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-450,258,000
Inventory
$33,897,000
Receivables
$29,915,000
ST Investments
$105,583,000
EBIT TTM
$-16,276,000
Pretax Income TTM
$-18,904,000
Interest Exp TTM
$2,628,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$206,223,008
EBITDA
$-13,834,000
Free Cash Flow
$-2,652,125
Enterprise Value
$548,867,968
Total Cash
$144,683,008
Total Debt
$42,947,000
Shares Out
44,349,283
Trailing EPS
$-0.39
Book Value
$4.05
ROE
-9.6%
ROA
-5.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 200,925,000 -22,330,000 -18,904,000 238,555,000 61,023,000 -675,000
Dec 2024 167,178,000 -35,248,000 -30,913,000 230,437,000 63,473,000 -12,425,000
Dec 2023 138,886,000 -46,931,000 -43,336,000 230,425,000 61,050,000 -18,713,000
Dec 2022 106,409,000 -59,609,000 -61,256,000 157,552,000 59,250,000 -41,655,000

TTM Snapshot

Revenues TTM
$123,072,000
NetIncome TTM
$-46,627,000
OpCashFlow TTM
$0
Assets (Latest)
$230,437,000
Forward EPS
$-0.35

Peers — same industry

TickerNameMarket CapLastDaily %
BWAY Brainsway Ltd. $636.40M $15.89
BRSYF Brainsway Ltd. $674.45M $16.84
SGP SpyGlass Pharma, Inc. $689.40M $20.62
BVS Bioventus Inc. $611.09M $9.02
CBLL Ceribell, Inc. $713.32M $18.80

News headlines (Yahoo Finance, 1h cache)

How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
2026-05-15 13:55 · Yahoo
Why Si-Bone Stock Soared by Almost 20% on Tuesday
2026-05-12 23:36 · Yahoo
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
2026-05-12 07:06 · Yahoo
SiBone Q1 Earnings Call Highlights
2026-05-12 02:14 · Yahoo
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
2026-05-12 00:05 · Yahoo
SI-Bone (SIBN) Q1 2026 Earnings Transcript
2026-05-11 22:32 · Yahoo
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
2026-05-11 20:09 · Yahoo
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
2026-04-30 20:09 · Yahoo
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
2026-04-20 20:09 · Yahoo
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”
2026-03-13 15:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.